Juvent Launches HydroxyBMD -- a Natural Supplement to Support Bone Health

RIVIERA BEACH, FL--(Marketwired - August 30, 2017) - Juvent (www.juvent.com) a leader in orthopaedic regenerative therapies for bone and musculoskeletal health announced today the launch of a unique natural bone health supplement; The HydroxyBMD System. It's unique in that it is one of the first to offer a calcium free (CF) option. It allows users who already believe that they are getting sufficient calcium in their diet but still desire additional clinically proven bone supporting nutrients like K2 and Silicon.

The HydroxyBMD system represents an innovative approach to biotransformation for individuals who have either just been diagnosed with low bone mineral density, are several years into their bone health regimen, or just want to make sure their giving their bones what they need. This all natural system combines formulas which include ingredients that promote better bone metabolism, better bone strength, better bone maintenance and better bone mineral density.

The HydroxyBMD system is divided into an AM(morning) and PM(evening) formulation making it easier to take and matches the body's natural rhythm of using vitamins in the morning and minerals at night.

The AM Calcium Free (CF) formulation combines Bonolive^® (a clinically studied pharmaceutical-grade olive extract which improved bone health and cardiovascular health in clinical studies), K2, Vitamin D, Choline/Silicon via ch-OSA (a patented Choline stabilized bioactive form of silicon that assures maximum absorption) to support healthy bones. It is a great start to a wholesome day for individuals seeking a natural way to promote overall bone and cardiovascular health.

The PM formulation focuses on minerals; chelated Calcium and Magnesium, Phosphorus, and a New Zealand micro-crystalline hydroxy-apatite concentrate (MCHC: a complex crystalline compound containing calcium, and numerous essential trace elements that naturally occur in healthy bone), patented 6 stage chelated minerals for maximum bioavailability that are less likely to cause discomfort. The amount of calcium can be customized with the help of their physician to match their need and lifestyle.

The choices that this system allows physicians and patients is rare but the CEO of Juvent, Rush Simonson, felt it was greatly needed. "Most bone health supplements today force patients and physicians to take a one size fits all approach to bone supplementation. There are legitimate health concerns expressed in the literature about individuals taking too much calcium or calcium that is not in a bio-similar form. HydroxyBMD answers all of those concerns."

"We worked for 5 years to bring a supplement that we felt matched the needs of our users and had the clinically proven effectiveness of our flagship technology; the Juvent Micro-Impact Platform. Juvent users are serious. They research all of their options and are educated consumers. The supplement arena is filled with substandard ingredients and suppliers that frankly kept us away. We hired one of the industry's leading consults to scour the country for one of the most reliable GMP suppliers and who has access to these key, leading edge ingredients. Juvent works with World class professional athletes, extreme sport enthusiests, leading research universities, children and everyday adults who are serious about bone health. Additionally as members of the National Osteoporosis Foundation's Corporate Round Table we are under a microscope. Whatever we do has to be the best and must pass clinical muster. The HydroxyBMD system rises to the challenge and is truly unique." says Simonson.

These are just some of the highlights of this new powerful supplement. We encourage Juvent users and interested bone health seekers to visit our specialized HydroxyBMD web site for more details and videos further defining the unique nature of this system. HydroxyBMD will go on sale in limited supply beginning tomorrow. The system is made in small lots to assure that the ingredients are fresh and highly potent.

About Juvent:
Juvent is a part of Regenerative Technologies Corporation, a privately held, Florida based company who manufactures the Juvent Micro-Impact Platform® here in the U.S. The platform provides non-invasive, micro-impact pulses to support bone health, lymphatic drainage, relieve joint and back pain, and enhance balance. The Class I medical exercise and rehabilitation device is the result of more than 20 years and $45 million in R&D, with many peer-reviewed journals articles and 6 human clinical studies and trials(completed or current) with backing from the National Institutes of Health (NIH), NASA, and the U.S. Army. Used by world-renowned medical doctors, trainers, physical therapists, and chiropractors, for more information, visit www.juvent.com or follow us on Twitter @JuventHealth, Facebook Juvent Health and, Facebook Juvent Sports.

In the U.S., the Juvent 1000N device is considered investigational for the treatment of osteoporosis or improvement/maintenance of bone mineral density (BMD). With the addition of HydroxyBMD, Juvent accomplished another milestone in the journey to better bone health. Juvent encourages all users to be under the care and supervision of a qualified physician who specializes in bone health. Poor bone health is a complicated condition and sufferers need a proper diagnosis and treatment plan. Juvent's Micro-Impact Platform and the HydroxyBMD are novel exercise devices and supplements that can play an important role in a coordinated treatment program.

Image Available: http://www.marketwire.com/library/MwGo/2017/8/29/11G144746/Images/Hydroxy_BMD_both_bottles-546bf9d5fe45b268b9dc12213b108894.jpg

Attachment Available: http://www.marketwire.com/library/MwGo/2017/8/29/11G144746/JR300347_Rev1_Hydroxy_Single_Pages-2c85de2a6ca8a4fba2fb3e49cc3c80fd.pdf